Fracture risk in CKD.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Gonadal Hormones in the Pathogenesis and Treatment of Bone Health in Patients with Chronic Kidney Disease: a Systematic Review and Meta-Analysis.Current osteoporosis reports · 2018
   Pooled it
2. Association of Increased Urinary Albumin With Risk of Incident Clinical Fracture and Rate of Hip Bone Loss: the Osteoporotic Fractures in Men Study.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2017
   Trial
3. The epidemiology of wrist fractures in older men: the Osteoporotic Fractures in Men (MrOS) study.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2018
   Article
4. Inflammatory markers and risk of hip fracture in older white women: the study of osteoporotic fractures.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2014
   Article
5. Vitamin D and chronic kidney disease-mineral bone disease (CKD-MBD).BoneKEy reports · 2014
   Article
6. Chronic kidney disease and the skeleton.Bone research · 2014
   Review
7. Matrix metalloproteinase-1 and -2 as markers of mineral bone disease in chronic kidney disease patients.Hippokratia
   Article

Corrections and comments

• Comment on
  Estimated GFR and fracture risk: a population-based study.2013

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as